Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica
Status:
Completed
Trial end date:
2015-11-20
Target enrollment:
Participant gender:
Summary
Phase 4, double-blind, placebo-controlled, four treatment, four sequence crossover study
comparing simulated driving performance, daytime sedation and cognition in healthy volunteers
administered therapeutic doses of Gralise® (Treatment A), Neurontin® (Treatment B), Lyrica®
(Treatment C) and placebo (Treatment D). All doses were administered under fed conditions.